
Insulet Corporation PODD
$ 201.51
0.01%
Quarterly report 2025-Q3
added 04-04-2026
Insulet Corporation Cash Conversion Cycle 2011-2026 | PODD
Annual Cash Conversion Cycle Insulet Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 187 | 232 | 238 | - | 233 | 114 | 98.2 | 89.9 | 63.4 | 81 | 44.9 | 46.5 | 22 | 74.4 | 57.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 238 | 22 | 113 |
Quarterly Cash Conversion Cycle Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 174 | 170 | - | - | 208 | 205 | - | - | - | - | - | - | - | - | 326 | - | 219 | 181 | 149 | - | 108 | 103 | 103 | 30.2 | 94.4 | 106 | 118 | 35 | 124 | 146 | 95.9 | 37.3 | 57.8 | 63.3 | 71.1 | 25.4 | 79.7 | 85.4 | 63.6 | 46.3 | 47 | 54.4 | 63.3 | 58.7 | 44.7 | 46.6 | 33.8 | 44 | 22.6 | 23.1 | 46.6 | 52.5 | 72 | 77 | 63.8 | 44.8 | 48.9 | 67.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 326 | 22.6 | 89.9 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
137 | $ 186.03 | 0.73 % | $ 13.9 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | ||
|
AdaptHealth Corp.
AHCO
|
20.1 | $ 12.63 | -1.14 % | $ 1.71 B | ||
|
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
263 | $ 296.18 | 1.28 % | $ 8.36 B | ||
|
Conformis
CFMS
|
165 | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 3.41 | 1.14 % | $ 128 M | ||
|
Bruker Corporation
BRKR
|
227 | $ 39.74 | -0.4 % | $ 5.92 K | ||
|
Boston Scientific Corporation
BSX
|
107 | $ 64.35 | 0.84 % | $ 95.3 B | ||
|
Cytosorbents Corporation
CTSO
|
104 | $ 0.6 | 1.14 % | $ 37.3 M | ||
|
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
18.2 | $ 1.95 | -1.77 % | $ 1.19 M | ||
|
ClearPoint Neuro
CLPT
|
217 | $ 10.51 | 1.25 % | $ 298 M | ||
|
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | ||
|
Inogen
INGN
|
48.9 | $ 6.27 | -1.1 % | $ 167 M | ||
|
Electromed
ELMD
|
180 | $ 25.59 | 1.51 % | $ 216 M | ||
|
IRIDEX Corporation
IRIX
|
105 | $ 1.02 | -0.71 % | $ 17.3 M | ||
|
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | ||
|
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | ||
|
LENSAR
LNSR
|
85.4 | $ 6.22 | 2.97 % | $ 74.4 M | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
81.2 | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
314 | $ 94.7 | -0.24 % | $ 12.8 B | ||
|
OrthoPediatrics Corp.
KIDS
|
714 | $ 17.96 | 0.56 % | $ 421 M | ||
|
Butterfly Network
BFLY
|
815 | $ 4.8 | 8.47 % | $ 1.02 B | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | ||
|
Myomo
MYO
|
82.3 | $ 0.8 | 2.29 % | $ 33.5 M | ||
|
Delcath Systems
DCTH
|
258 | $ 10.98 | 0.92 % | $ 393 M | ||
|
Inspire Medical Systems
INSP
|
248 | $ 57.39 | 0.93 % | $ 1.69 B | ||
|
CONMED Corporation
CNMD
|
212 | $ 39.24 | -1.23 % | $ 1.22 B | ||
|
LivaNova PLC
LIVN
|
113 | $ 64.84 | -0.23 % | $ 3.54 B | ||
|
Integer Holdings Corporation
ITGR
|
96.8 | $ 87.21 | -1.59 % | $ 3.03 B | ||
|
FONAR Corporation
FONR
|
234 | $ 18.75 | -0.05 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
283 | $ 77.86 | -0.43 % | $ 45.5 B | ||
|
NanoVibronix
NAOV
|
853 | - | - | $ 1.08 M |